Please assess the completion status of the following clinical trial:

Trial Title: Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Age \> 18 Skin thickening \< 3 years Immunosuppressant use \< 4 months Proximal skin involvement to face/neck, elbow or knee~Exclusion Criteria:~Previous use of more than 4 months of methotrexate, mycophenolate mofetil, cyclophosphamide or other immunosuppressive treatments~Previous use of immunosuppressant therapy other than methotrexate, mycophenolate mofetil or cyclophosphamide within previous months~Previous stem cell transplantation therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Methotrexate (Type: None): Patients treated with Methotrexate at the entry of the study.
- Mycophenolate Mofetil (Type: None): Patients treated with Mycophenolate Mofetil at the entry of the study.
- Cyclophosphamide (Type: None): Patients treated with Cyclophosphamide at the entry of the study
- No Immunosuppressant (Type: None): Patients without immunosuppressant treatment at the entry of the study

Based on this trial design, predict the completion outcome and termination type (if applicable).